Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Sherine Kuriyakose, MSc

GlaxoSmithKline, India

Disclosure(s): GSK: GSK Employee

Poster(s):

2139 - Immunogenicity, reactogenicity and safety of a Respiratory Syncytial Virus prefusion F (RSVPreF3) candidate vaccine co-administered with the seasonal quadrivalent influenza vaccine in older adults
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET